Davenport & CO LLC Astrazeneca PLC Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

A detailed history of Davenport & CO LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Davenport & CO LLC holds 14,535 shares of AZN stock, worth $953,932. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,535

Previous 13,811 5.24%

Holding current value

$953,932

Previous $1.08 Million 5.11%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$76.67 - $87.62 $55,509 - $63,436	724 Added 5.24%	14,535 $1.13 Million
Q2 2024 Aug 06, 2024	BUY	$66.81 - $80.83 $91,997 - $111,302	1,377 Added 11.07%	13,811 $1.08 Million
Q1 2024 May 03, 2024	SELL	$61.03 - $69.57 $7,689 - $8,765	-126 Reduced 1.0%	12,434 $842,000
Q4 2023 Jan 23, 2024	SELL	$61.89 - $69.28 $2,723 - $3,048	-44 Reduced 0.35%	12,560 $845,000
Q3 2023 Oct 17, 2023	SELL	$64.85 - $71.7 $55,252 - $61,088	-852 Reduced 6.33%	12,604 $853,000
Q2 2023 Jul 20, 2023	BUY	$69.91 - $75.81 $19,434 - $21,075	278 Added 2.11%	13,456 $963,000
Q1 2023 Apr 27, 2023	SELL	$63.15 - $71.6 $1.18 Million - $1.34 Million	-18,729 Reduced 58.7%	13,178 $914,000
Q4 2022 Jan 20, 2023	SELL	$54.21 - $70.44 $63,913 - $83,048	-1,179 Reduced 3.56%	31,907 $0
Q3 2022 Oct 11, 2022	SELL	$53.02 - $135.75 $73,114 - $187,199	-1,379 Reduced 4.0%	33,086 $1.81 Million
Q2 2022 Jul 18, 2022	SELL	$59.26 - $71.14 $379,264 - $455,296	-6,400 Reduced 15.66%	34,465 $2.28 Million
Q1 2022 May 02, 2022	BUY	$55.72 - $67.12 $419,460 - $505,279	7,528 Added 22.58%	40,865 $2.71 Million
Q4 2021 Feb 10, 2022	BUY	$54.02 - $63.83 $1.19 Million - $1.41 Million	22,093 Added 196.49%	33,337 $1.94 Million
Q3 2021 Oct 14, 2021	SELL	$55.56 - $60.79 $4,611 - $5,045	-83 Reduced 0.73%	11,244 $675,000
Q2 2021 Jul 28, 2021	BUY	$48.42 - $60.18 $2,663 - $3,309	55 Added 0.49%	11,327 $678,000
Q1 2021 Apr 28, 2021	SELL	$47.16 - $54.44 $16,458 - $18,999	-349 Reduced 3.0%	11,272 $560,000
Q4 2020 Jan 13, 2021	SELL	$48.52 - $58.02 $9,704 - $11,604	-200 Reduced 1.69%	11,621 $581,000
Q3 2020 Oct 15, 2020	BUY	$53.07 - $61.1 $17,141 - $19,735	323 Added 2.81%	11,821 $648,000
Q1 2020 May 05, 2020	BUY	$37.79 - $51.33 $2,040 - $2,771	54 Added 0.47%	11,498 $514,000
Q4 2019 Jan 22, 2020	SELL	$42.46 - $50.46 $934 - $1,110	-22 Reduced 0.19%	11,444 $571,000
Q2 2019 Jul 10, 2019	SELL	$37.28 - $41.68 $15,545 - $17,380	-417 Reduced 3.51%	11,466 $473,000
Q1 2019 Apr 17, 2019	SELL	$35.49 - $43.02 $48,443 - $58,722	-1,365 Reduced 10.3%	11,883 $480,000
Q4 2018 Jan 28, 2019	BUY	$36.86 - $41.49 $7,924 - $8,920	215 Added 1.65%	13,248 $503,000
Q3 2018 Oct 11, 2018	BUY	$34.76 - $39.72 $6,222 - $7,109	179 Added 1.39%	13,033 $516,000
Q2 2018 Jul 09, 2018	BUY	$34.55 - $37.05 $24,737 - $26,527	716 Added 5.9%	12,854 $451,000
Q1 2018 Apr 04, 2018	BUY	$32.97 - $36.63 $23,540 - $26,153	714 Added 6.25%	12,138 $424 Million
Q4 2017 Jan 17, 2018	BUY	$32.09 - $34.78 $7,701 - $8,347	240 Added 2.15%	11,424 $396 Million
Q3 2017 Oct 12, 2017	BUY	$28.96 - $34.0 $323,888 - $380,256	11,184	11,184 $379 Million

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account